Phase 3 Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Women aged 18 and over who have been diagnosed with breast cancer confirmed by a laboratory test (such as a biopsy).
- People with breast cancer whose treatment plan includes a chemotherapy drug called paclitaxel.
- People whose ability to carry out daily activities is rated above 2 on a standard medical scale used to measure how cancer affects daily functioning (confirm with trial site).
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who already have signs or symptoms of nerve damage (such as numbness, tingling, or pain) before the trial begins.
- People who have diabetes, alcohol-related illness, heart failure, or who are pregnant or breastfeeding.
- People who are currently taking vitamins or supplements that may interfere with the trial treatment.
- People who have received chemotherapy at any time in the past.
- People with liver problems or reduced liver function.
- People who have previously had an allergic reaction to a substance called hesperidin.
- People who have previously had an allergic reaction to a substance called diosmin.
- People with kidney problems or reduced kidney function.
- People who are unable to consistently take paclitaxel as prescribed.
- People who are unable to consistently take the hesperidin and diosmin provided during the trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 03-01148898967
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Primary endpoints
Changes in serum levels of the following biomarker:Nerve growth factor (NGF); Changes in serum levels of the following biomarker :Malondialdehyde (MDA).; Changes in serum levels of the following biomarker:Interleukin-1 beta (IL-1 β).; Changes in serum levels of the following biomarker: Tumor necrosis Factor-Alpha (TNF- α) .
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.